No. 标题 发布时间
[Interview(EDAILY)] Overcoming the Inefficacious Colon Cancer Drugs Through Biomarker based Treatments
Dong-Hoon Jin, CEO of Wellmarker Bio Gives Speech about ‘Correlation between Biomarker and Anticancer Drug Development’ at the ‘KOREA BIO INV...
[Interview(Maeil Business Newspaper)] Wellmarker Bio Develops Anticancer Treatment based on Gene Expression
[Interview(Hankyung)] Wellmarker Bio Develops 5 First-in-Class Candidates that Could Improve the Drug's Efficacy
WMBIO once again Enters into an Agreement with KDDF to Acquire the On-going Follow-up Project of WM-S1